Get Travere Therapeutics alerts:Check Out Our Latest Stock Analysis on Travere TherapeuticsTravere Therapeutics Price PerformanceShares of TVTX traded up $0.96 during mid-day trading on Thursday, hitting $56.52. Travere Therapeutics (NASDAQ:TVTX – Get Free Report) last posted its quarterly earnings data on Monday, May 4th. Travere Therapeutics had a negative net margin of 4.00% and a negative return on equity of 26.16%. As a group, equities analysts expect that Travere Therapeutics will post -0.31 earnings per share for the current fiscal year. Featured StoriesReceive News & Ratings for Travere Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Travere Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.